Sino Biological, a Beijing reagents developer, raised $29 million in a Series A round led by Qiming Venture Partners, a China VC with interest in life sciences. Founded in 2007 by MIT professor, Dr. Daniel I.C. Wang, and his former student, Dr. Liangzhi Xie, Sino Biological offers a large selection of reagents for life science research and drug development. It also provides CRO services for protein and antibody discovery, research, development, production and commercialization.
